R. David Anderson, MD, MS, FACC, FSCAI

The purpose of this trial is to generate clinical evidence on valve safety and performance of self-expanding (SE) versus balloon-expandable (BE) transcatheter aortic valve replacement (TAVR) in subjects with a small aortic annulus and symptomatic…

Investigator

R. David Anderson

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All

This clinical trial will explore the efficacy and safety of GCSF-mobilized autologous CD34+ cells for the treatment of CMD in adults currently experiencing angina and with no obstructive coronary artery disease. Eligible subjects will receive a…

Investigator

R. David Anderson

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All

Prospective, multi-center, 2:1 randomized (Treatment : Sham Control), sham-controlled, double-blinded trial to compare treatment using the CardiAMP cell therapy system to sham treatment Treatment Group: Subjects treated with aBMC using the CardiAMP…

Investigator

R. David Anderson

Status

Accepting Candidates

Ages

21 Years - 80 Years

Sexes

All